153 related articles for article (PubMed ID: 36896690)
21. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.
Anderson KR; Schoch JJ; Lohse CM; Hand JL; Davis DM; Tollefson MM
J Am Acad Dermatol; 2016 Jan; 74(1):120-6. PubMed ID: 26494585
[TBL] [Abstract][Full Text] [Related]
22. Infantile hemangioma with minimal or arrested growth as the skin manifestation of PHACE syndrome.
Valdivielso-Ramos M; Torrelo A; Martin-Santiago A; Campos M; Conde E; de la Cueva P; Lopez-Gutierrez JC
Pediatr Dermatol; 2018 Sep; 35(5):622-627. PubMed ID: 29984853
[TBL] [Abstract][Full Text] [Related]
23. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.
Thaivalappil S; Bauman N; Saieg A; Movius E; Brown KJ; Preciado D
JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1026-31. PubMed ID: 24135743
[TBL] [Abstract][Full Text] [Related]
24. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of lip infantile haemangiomas and main risk factors for ulceration: an 8-year retrospective study of 69 Chinese infants.
Yu L; Li LL; Yan P; Deng L; Gan XL; Yao XJ; Zhu ZH; Zhang TD
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2135-2139. PubMed ID: 32118308
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of propranolol for cutaneous hemangiomas in premature children.
Brazzelli V; Giorgini C; Barruscotti S; Codazzi CA; Mannarino S; Tzialla C; Stronati M; Marseglia GL; Borroni G
G Ital Dermatol Venereol; 2016 Oct; 151(5):485-91. PubMed ID: 25692776
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of infantile hemangiomas with aggressive, persistent, and destructive ulceration.
Gautam A; Frieden IJ; Shah SD; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Buros A; Fernández Faith E
Pediatr Dermatol; 2023; 40(6):996-1002. PubMed ID: 37845188
[TBL] [Abstract][Full Text] [Related]
28. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
29. Infantile Hemangioma: An Updated Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(1):55-69. PubMed ID: 32384034
[TBL] [Abstract][Full Text] [Related]
30. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
31. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
32. Tocolysis with the β-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants.
Mayer M; Minichmayr A; Klement F; Hroncek K; Wertaschnigg D; Arzt W; Wiesinger-Eidenberger G; Lechner E
Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F108-11. PubMed ID: 22611112
[TBL] [Abstract][Full Text] [Related]
33. Early growth of infantile hemangiomas: what parents' photographs tell us.
Tollefson MM; Frieden IJ
Pediatrics; 2012 Aug; 130(2):e314-20. PubMed ID: 22826568
[TBL] [Abstract][Full Text] [Related]
34. An epidemiological study investigating the relationship between chorangioma and infantile hemangioma.
Selmin A; Foltran F; Chiarelli S; Ciullo R; Gregori D
Pathol Res Pract; 2014 Sep; 210(9):548-53. PubMed ID: 24836731
[TBL] [Abstract][Full Text] [Related]
35. Lesion Morphology in Multifocal Infantile Hemangiomas.
Reimer A; Hoeger PH
Pediatr Dermatol; 2016 Nov; 33(6):621-626. PubMed ID: 27601263
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and Management of Infantile Hemangiomas in the Neonate.
Harter N; Mancini AJ
Pediatr Clin North Am; 2019 Apr; 66(2):437-459. PubMed ID: 30819347
[TBL] [Abstract][Full Text] [Related]
37. Tocolysis with the β
Hudalla H; Karmen C; Bruckner T; Wallwiener S; Fluhr H; Michael Z; Freis A; Maul H; Strowitzki T; Pöschl J; Kuon RJ
Arch Gynecol Obstet; 2018 Sep; 298(3):521-527. PubMed ID: 29938346
[TBL] [Abstract][Full Text] [Related]
38. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment.
Rodríguez Bandera AI; Sebaratnam DF; Wargon O; Wong LF
J Am Acad Dermatol; 2021 Dec; 85(6):1379-1392. PubMed ID: 34419524
[TBL] [Abstract][Full Text] [Related]
39. Incidence and clinical factors associated with ulceration in infantile hemangiomas.
Fernández Faith E; Shah SD; Braun M; Pope E; Lara-Corrales I; Witman PM; Harfmann K; Bradley F; Keesari R; Jackson K; Hallagan A; Frieden IJ
J Am Acad Dermatol; 2023 Feb; 88(2):414-420. PubMed ID: 36404484
[TBL] [Abstract][Full Text] [Related]
40. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
